Operating Expenses

Impairment of Goodwill and Purchased Intangible Assets

Edwards Lifesciences Impairment of Goodwill and Purchased Intangible Assets increased by 162.4% to $123.60M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2020
Last reportedQ1 2026May 6, 2026

How to read this metric

Higher values signal poor performance or overpayment for past acquisitions, negatively impacting earnings.

Detailed definition

Charges recognized when the carrying value of goodwill or acquired intangible assets exceeds their fair value. This indi...

Peer comparison

Commonly reported by companies that have engaged in significant M&A activity.

Metric ID: klac_impairment_of_goodwill_and_purchased_intangible_assets

Historical Data

12 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q4 '23Q2 '24Q1 '25Q2 '25Q1 '26
Value$1.00M$1.00M$1.00M$13.78M$13.78M$13.78M$13.78M$0.00$0.00$0.00$47.10M$123.60M
QoQ Change+0.0%+0.0%>999%+0.0%+0.0%+0.0%-100.0%+162.4%
YoY Change>999%>999%>999%-100.0%
Range$0.00$123.60M
CAGR+476.4%
Avg YoY Growth+933.1%
Median YoY Growth>999%

Impairment of Goodwill and Purchased Intangible Assets at Other Companies

Frequently Asked Questions

What is Edwards Lifesciences's impairment of goodwill and purchased intangible assets?
Edwards Lifesciences (EW) reported impairment of goodwill and purchased intangible assets of $123.60M in Q1 2026.
What does impairment of goodwill and purchased intangible assets mean?
Non-cash charges for the reduction in value of acquired assets or goodwill.